TGFB1 and neoplasm: However, microarray profiling from PyMT/ETP tumors uncovered an upregulation of pathways related to the cell cycle, pluripotency, Janus kinase (JAK) signaling, and immune checkpoint proteins [21], suggesting that the ETP/TGF-β axis may also promote tumor progression in an EMT-independent manner.